Co-Immunoprecipitation of the RAF-MEK Complex to Assess Disruption by the MEK Inhibitor Trametinib in BRAF-V600E A375 Melanoma Cells
A deterministic, publicly-verifiable summary of how reproducible and transparent this protocol is, computed from open signals only and never from private lab data.